Ascentage Pharma Group International (AAPG) Enterprise Value (2022 - 2024)
Historic Enterprise Value for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q4 2024 value amounting to -$124.3 million.
- Ascentage Pharma Group International's Enterprise Value rose 1376.01% to -$124.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$124.3 million, marking a year-over-year increase of 1376.01%. This contributed to the annual value of -$124.3 million for FY2024, which is 1257.17% up from last year.
- Ascentage Pharma Group International's Enterprise Value amounted to -$124.3 million in Q4 2024, which was up 1376.01% from -$144.2 million recorded in Q4 2023.
- Over the past 5 years, Ascentage Pharma Group International's Enterprise Value peaked at -$124.3 million during Q4 2024, and registered a low of -$189.2 million during Q4 2022.
- Moreover, its 3-year median value for Enterprise Value was -$144.2 million (2023), whereas its average is -$152.6 million.
- As far as peak fluctuations go, Ascentage Pharma Group International's Enterprise Value soared by 2380.02% in 2023, and later skyrocketed by 1376.01% in 2024.
- Ascentage Pharma Group International's Enterprise Value (Quarter) stood at -$189.2 million in 2022, then increased by 23.8% to -$144.2 million in 2023, then grew by 13.76% to -$124.3 million in 2024.
- Its last three reported values are -$124.3 million in Q4 2024, -$144.2 million for Q4 2023, and -$189.2 million during Q4 2022.